Asked by: John Lamont (Conservative - Berwickshire, Roxburgh and Selkirk)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether each approved covid-19 vaccine will be distributed across the UK according to population.
Answered by Jo Churchill
As health is a devolved matter, the United Kingdom Government is working closely with the devolved administrations to ensure successful deployment of a COVID-19 vaccine across the whole of the UK. This includes considerations of planning and key decisions which will need to be aligned across the devolved administrations. The Government will distribute available COVID-19 vaccines on an equitable basis across the UK.
Asked by: John Lamont (Conservative - Berwickshire, Roxburgh and Selkirk)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, for each of the (a) five Regional Testing Centres and (b) 13 Mobile Testing Units in Scotland, (i) on what date each site opened, (ii) what the daily testing capacity is, (iii) the number of tests that have been carried out on each day since the site opened, (iv) the average number of tests carried out per day since the site opened and (v) the total number of tests carried out to date.
Answered by Nadine Dorries
We do not publish data in this format.
Asked by: John Lamont (Conservative - Berwickshire, Roxburgh and Selkirk)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, when he plans to respond to Question 46771, tabled by the hon. Member for Berwickshire, Roxburgh and Selkirk on 13 May 2020.
Answered by Nadine Dorries
We take parliamentary scrutiny incredibly seriously and it is fundamentally important that hon. Members are provided with accurate and timely information to enable them to hold the Government to account. We are working rapidly to provide all Members with accurate answers to their questions, as well as supporting the Government’s response to the unprecedented challenge of the COVID-19 pandemic.
The hon. Member’s question will be answered as soon as possible.
Asked by: John Lamont (Conservative - Berwickshire, Roxburgh and Selkirk)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how much funding the Government has provided to set up NHS Louisa Jordan.
Answered by Edward Argar
The National Health Service in Scotland is devolved to the Scottish Parliament and all policy and spending decisions are made in Scotland. The devolved administrations receive funding through the Barnett formula. On 13 April the Chancellor announced almost £2 billion from the COVID-19 emergency response fund will go to the devolved administrations through the Barnett formula.
Asked by: John Lamont (Conservative - Berwickshire, Roxburgh and Selkirk)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what further steps he will take to increase co-operation between his Department and the devolved Administrations.
Answered by Caroline Dinenage
The Department continues to work closely with its counterparts in the devolved administrations. There is regular Ministerial engagement across the four nations, involving the health ministers from the Welsh and Scottish Governments and the Permanent Secretary of the Northern Ireland Department of Health. Detailed and extensive collaboration between officials across the four nations is continuing, with engagement across a full range of policy issues.
Asked by: John Lamont (Conservative - Berwickshire, Roxburgh and Selkirk)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of implementing a UK-wide scheme for the purchase and distribution of expensive drugs and medical supplies that are used to treat rare conditions.
Answered by Steve Brine
We have no plans to assess the potential merits of implementing a United Kingdom-wide scheme for the purchase and distribution of expensive drugs and medical supplies that are used to treat rare conditions. It is for the National Health Service in England and the devolved administrations to make decisions in the best interest of their patients, including those with rare diseases, to ensure access to the medicines and medical supplies they need.